Comparison between Medplus Health IPO and Metro Brands IPO.
Medplus Health IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Metro Brands IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Medplus Health IPO is up to ₹1,398.29 Cr whereas the issue size of the Metro Brands IPO is up to ₹1,367.51 Cr. The final issue price of Medplus Health IPO is ₹796.00 per share and of Metro Brands IPO is ₹500.00 per share.
| Medplus Health IPO | Metro Brands IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹780.00 per share | ₹485.00 per share |
| Issue Price (Upper) | ₹796.00 per share | ₹500.00 per share |
| Issue Price (Final) | ₹796.00 per share | ₹500.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹78.00 per share | |
| Market Lot Size | 18 shares | 30 shares |
| Fresh Issue Size | 75,44,511 shares | 59,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹600.31 Cr | up to ₹295.00 Cr |
| OFS Issue Size | 1,00,28,831 shares | 2,14,50,100 shares |
| OFS Issue Size (Amount) | up to ₹797.98 Cr | up to ₹1,072.51 Cr |
| Issue Size Total | 1,75,73,342 shares | 2,73,50,100 shares |
| Issue Size Total (Amount) | up to ₹1,398.29 Cr | up to ₹1,367.51 Cr |
Medplus Health IPO opens on Dec 13, 2021, while Metro Brands IPO opens on Dec 10, 2021. The closing date of Medplus Health IPO and Metro Brands IPO is Dec 15, 2021, and Dec 14, 2021, respectively.
| Medplus Health IPO | Metro Brands IPO | |
|---|---|---|
| Anchor Bid Date | Dec 10, 2021 | Dec 09, 2021 |
| Issue Open | Dec 13, 2021 | Dec 10, 2021 |
| Issue Close | Dec 15, 2021 | Dec 14, 2021 |
| Basis Of Allotment (Tentative) | Dec 20, 2021 | Dec 17, 2021 |
| Initiation of Refunds (Tentative) | Dec 21, 2021 | Dec 20, 2021 |
| Credit of Share (Tentative) | Dec 22, 2021 | Dec 21, 2021 |
| Listing date (Tentative) | Dec 23, 2021 | Dec 22, 2021 |
| Anchor Lockin End date 1 | Jan 19, 2022 | Jan 16, 2022 |
| Anchor Lockin End date 2 | Mar 20, 2022 | Mar 17, 2022 |
Medplus Health IPO P/E ratio is , as compared to Metro Brands IPO P/E ratio of .
| Medplus Health IPO | Metro Brands IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 43.16 | 84.02 | ||||
| Promoter Shareholding (Post-Issue) | 40.43 | 74.27 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹9496.73 Cr. | ₹13575.37 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Medplus Health IPO Retail Individual Investors (RII) are offered 61,26,297 shares while in Metro Brands IPO retail investors are offered 61,26,297 shares. Qualified Institutional Buyers (QIB) are offered 35,00,741 shares in Medplus Health IPO and 54,70,020 shares in Metro Brands IPO.
| Medplus Health IPO | Metro Brands IPO | |
|---|---|---|
| Anchor Investor Reservation | 52,51,111 shares | 82,05,030 shares |
| Market Maker Reservation | ||
| QIB | 35,00,741 shares | 54,70,020 shares |
| NII | 26,25,556 shares | 41,02,515 shares |
| RII | 61,26,297 shares | 95,72,535 shares |
| Employee | 69,637 shares | |
| Others | ||
| Total | 1,75,73,342 shares | 2,73,50,100 shares |
Medplus Health IPO subscribed 52.59x in total, whereas Metro Brands IPO subscribed 3.64x.
| Medplus Health IPO | Metro Brands IPO | |
|---|---|---|
| QIB (times) | 111.90x | 8.49x |
| NII (times) | 85.33x | 3.02x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 5.24x | 1.13x |
| Employee (times) | 3.05x | |
| Other (times) | ||
| Total (times) | 52.59x | 3.64x |
